Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Tarsus Pharmaceuticals (TARS) over the last 5 years, with Q3 2025 value amounting to 0.71.
- Tarsus Pharmaceuticals' Asset Utilization Ratio rose 10661.07% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 10661.07%. This contributed to the annual value of 0.57 for FY2024, which is 70522.35% up from last year.
- Per Tarsus Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.71 for Q3 2025, which was up 10661.07% from 0.59 recorded in Q2 2025.
- In the past 5 years, Tarsus Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.71 in Q3 2025 and a low of 0.06 during Q2 2023
- In the last 5 years, Tarsus Pharmaceuticals' Asset Utilization Ratio had a median value of 0.18 in 2021 and averaged 0.25.
- Per our database at Business Quant, Tarsus Pharmaceuticals' Asset Utilization Ratio plummeted by 7706.2% in 2022 and then soared by 64311.03% in 2024.
- Tarsus Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.31 in 2021, then plummeted by 63.99% to 0.11 in 2022, then crashed by 41.22% to 0.07 in 2023, then soared by 643.11% to 0.49 in 2024, then surged by 46.41% to 0.71 in 2025.
- Its Asset Utilization Ratio was 0.71 in Q3 2025, compared to 0.59 in Q2 2025 and 0.53 in Q1 2025.